Product Information
IVABRADINE HCL 7.5 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.7371 per EA under NDC 72205033760. Its NADAC has been published 27 times since Dec 24, 2025.
Strength
7.5 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205033760
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213483On Market Since
4/28/2025
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 7.5 MG TABLET has been published 27 times since Dec 24, 2025, and over the history we have for it it has declined 64.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7371 per EA |
|---|---|
| All-time high | $2.0762 (Jan 14, 2026) |
| All-time low | $0.7371 (Jun 17, 2026) |
| 52-week high | $2.0762 |
| 52-week low | $0.7371 |
| Median price | $0.9937 |
| Average price | $1.2212 |
| Largest weekly change | -25.7% (Feb 18, 2026) |
| Weeks tracked | 27 |
| Tracking since | Dec 24, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 7.5 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $0.7371 per EA (NDC 72205033760), effective Jun 24, 2026.
How has the price of IVABRADINE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 7.5 MG TABLET has declined 64.5%. It has been tracked across 27 weekly CMS publications since Dec 24, 2025.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 7.5 MG TABLET?
Since Dec 24, 2025, the NADAC for IVABRADINE HCL 7.5 MG TABLET has ranged from a low of $0.7371 (Jun 17, 2026) to a high of $2.0762 (Jan 14, 2026), with a median of $0.9937 per EA.
Are there cheaper alternatives to IVABRADINE HCL 7.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as IVABRADINE HCL 7.5 MG TABLET, but none are currently priced below it.
Who manufactures IVABRADINE HCL 7.5 MG TABLET?
IVABRADINE HCL 7.5 MG TABLET (NDC 72205033760) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification